Ethyol For Xerostomia Should Specify Post-Op Head & Neck Cancer Patients
Executive Summary
U.S. Bioscience/Alza's Ethyol (amifostine) should be approved for prevention of radiation-induced moderate-to-severe xerostomia in post-operative head and neck cancer patients, FDA's Oncologic Drugs Advisory Committee recommended June 8.